Glycogen synthase kinase-3 |
IC50 |
= |
630.96 |
nM |
Inhibition of GSK3 |
CHEMBL1146115 |
Serine/threonine-protein kinase AKT |
Inhibition |
= |
-4.15 |
% |
GSK_PKIS: AKT1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase AKT2 |
Inhibition |
= |
-3.57 |
% |
GSK_PKIS: AKT2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase AKT3 |
Inhibition |
= |
-4.17 |
% |
GSK_PKIS: AKT3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
G protein-coupled receptor kinase 6 |
Inhibition |
= |
2.45 |
% |
GSK_PKIS: GRK6 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
G protein-coupled receptor kinase 7 |
Inhibition |
= |
1.71 |
% |
GSK_PKIS: GRK7 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase MRCK-A |
Inhibition |
= |
1.59 |
% |
GSK_PKIS: MRCKA mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase MRCK beta |
Inhibition |
= |
0.38 |
% |
GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Ribosomal protein S6 kinase alpha 5 |
Inhibition |
= |
-0.31 |
% |
GSK_PKIS: MSK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Ribosomal protein S6 kinase alpha 4 |
Inhibition |
= |
2.44 |
% |
GSK_PKIS: MSK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Ribosomal protein S6 kinase 1 |
Inhibition |
= |
-0.32 |
% |
GSK_PKIS: p70s6K1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
3-phosphoinositide dependent protein kinase-1 |
Inhibition |
= |
0.77 |
% |
GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
cAMP-dependent protein kinase alpha-catalytic subunit |
Inhibition |
= |
-1.92 |
% |
GSK_PKIS: PKA mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C alpha |
Inhibition |
= |
-2.58 |
% |
GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C beta |
Inhibition |
= |
3.24 |
% |
GSK_PKIS: PKC-beta1 (splice variant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C eta |
Inhibition |
= |
3.47 |
% |
GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C gamma |
Inhibition |
= |
0.93 |
% |
GSK_PKIS: PKC-gamma mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C iota |
Inhibition |
= |
0.58 |
% |
GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C theta |
Inhibition |
= |
0.62 |
% |
GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C beta |
Inhibition |
= |
2.34 |
% |
GSK_PKIS: PKC-beta2 (splice variant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C mu |
Inhibition |
= |
-2.1 |
% |
GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase D2 |
Inhibition |
= |
-4.34 |
% |
GSK_PKIS: PRKD2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C nu |
Inhibition |
= |
-3.34 |
% |
GSK_PKIS: PRKD3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
cGMP-dependent protein kinase 1 beta |
Inhibition |
= |
0.67 |
% |
GSK_PKIS: PRKG1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
cGMP-dependent protein kinase 2 |
Inhibition |
= |
3.29 |
% |
GSK_PKIS: PRKG2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PRKX |
Inhibition |
= |
1.92 |
% |
GSK_PKIS: PRKX mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Rho-associated protein kinase 1 |
Inhibition |
= |
0.59 |
% |
GSK_PKIS: ROCK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Rho-associated protein kinase 2 |
Inhibition |
= |
3.27 |
% |
GSK_PKIS: ROCK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Ribosomal protein S6 kinase alpha 1 |
Inhibition |
= |
2.62 |
% |
GSK_PKIS: RSK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Ribosomal protein S6 kinase alpha 3 |
Inhibition |
= |
2.12 |
% |
GSK_PKIS: RSK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Ribosomal protein S6 kinase alpha 2 |
Inhibition |
= |
-0.37 |
% |
GSK_PKIS: RSK3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Ribosomal protein S6 kinase alpha 6 |
Inhibition |
= |
-0.06 |
% |
GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Sgk1 |
Inhibition |
= |
1.3 |
% |
GSK_PKIS: SGK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Sgk2 |
Inhibition |
= |
1.67 |
% |
GSK_PKIS: SGK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Sgk3 |
Inhibition |
= |
3.19 |
% |
GSK_PKIS: SGK3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
AMP-activated protein kinase, alpha-1 subunit |
Inhibition |
= |
1.05 |
% |
GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
AMP-activated protein kinase, alpha-2 subunit |
Inhibition |
= |
-1.1 |
% |
GSK_PKIS: AMPKA2 (A2B1G1) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
NUAK family SNF1-like kinase 1 |
Inhibition |
= |
2.39 |
% |
GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
BR serine/threonine-protein kinase 1 |
Inhibition |
= |
-0.01 |
% |
GSK_PKIS: BRSK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
BR serine/threonine-protein kinase 2 |
Inhibition |
= |
-0.23 |
% |
GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
CaM kinase I delta |
Inhibition |
= |
0.54 |
% |
GSK_PKIS: CAMK1D mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
CaM kinase II alpha |
Inhibition |
= |
0.58 |
% |
GSK_PKIS: CAMK2A mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
CaM kinase II delta |
Inhibition |
= |
-1.07 |
% |
GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
CaM kinase IV |
Inhibition |
= |
-2.88 |
% |
GSK_PKIS: CAMK4 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Chk1 |
Inhibition |
= |
0.34 |
% |
GSK_PKIS: CHEK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Chk2 |
Inhibition |
= |
-0.94 |
% |
GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Death-associated protein kinase 1 |
Inhibition |
= |
-0.67 |
% |
GSK_PKIS: DAPK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase DCLK2 |
Inhibition |
= |
-3.07 |
% |
GSK_PKIS: DCAMKL2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase-activated protein kinase 2 |
Inhibition |
= |
-0.39 |
% |
GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase-activated protein kinase 3 |
Inhibition |
= |
-0.9 |
% |
GSK_PKIS: MAPKAPK3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase MARK1 |
Inhibition |
= |
1.01 |
% |
GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase c-TAK1 |
Inhibition |
= |
1.08 |
% |
GSK_PKIS: MARK3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
MAP/microtubule affinity-regulating kinase 4 |
Inhibition |
= |
0.84 |
% |
GSK_PKIS: MARK4 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Maternal embryonic leucine zipper kinase |
Inhibition |
= |
-1.92 |
% |
GSK_PKIS: MELK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase-interacting serine/threonine-protein kinase MNK1 |
Inhibition |
= |
0.43 |
% |
GSK_PKIS: MKNK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase signal-integrating kinase 2 |
Inhibition |
= |
3.13 |
% |
GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
MAP/microtubule affinity-regulating kinase 2 |
Inhibition |
= |
0.99 |
% |
GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
PAS domain-containing serine/threonine-protein kinase |
Inhibition |
= |
1.87 |
% |
GSK_PKIS: PASK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Phosphorylase kinase gamma subunit 1 |
Inhibition |
= |
-0.02 |
% |
GSK_PKIS: PHKG1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Phosphorylase kinase gamma subunit 2 |
Inhibition |
= |
1.83 |
% |
GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PIM1 |
Inhibition |
= |
-0.24 |
% |
GSK_PKIS: PIM1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PIM2 |
Inhibition |
= |
-3.51 |
% |
GSK_PKIS: PIM2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PIM3 |
Inhibition |
= |
3.67 |
% |
GSK_PKIS: PIM3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase-activated protein kinase 5 |
Inhibition |
= |
0.59 |
% |
GSK_PKIS: PRAK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase SIK1 |
Inhibition |
= |
1.88 |
% |
GSK_PKIS: SNF1LK (SIK) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase SIK2 |
Inhibition |
= |
9.07 |
% |
GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase TBK1 |
Inhibition |
= |
0.99 |
% |
GSK_PKIS: TBK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Testis-specific serine/threonine-protein kinase 1 |
Inhibition |
= |
0.41 |
% |
GSK_PKIS: TSSK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Testis-specific serine/threonine-protein kinase 2 |
Inhibition |
= |
0.37 |
% |
GSK_PKIS: TSSK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Casein kinase I alpha |
Inhibition |
= |
0.17 |
% |
GSK_PKIS: CK1a mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Casein kinase I gamma 1 |
Inhibition |
= |
-3.8 |
% |
GSK_PKIS: CK1-g1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Casein kinase I gamma 2 |
Inhibition |
= |
-3.36 |
% |
GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Casein kinase I isoform gamma-3 |
Inhibition |
= |
-3.39 |
% |
GSK_PKIS: CK1-g3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Cyclin-dependent kinase 1 |
Inhibition |
= |
-3.5 |
% |
GSK_PKIS: CDK1/cyclinB mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Cyclin-dependent kinase 2 |
Inhibition |
= |
-3.99 |
% |
GSK_PKIS: CDK2/cyclinA mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Cyclin-dependent kinase 2 |
Inhibition |
= |
-3.22 |
% |
GSK_PKIS: CDK2/cyclinE mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
CDK3/Cyclin E |
Inhibition |
= |
-0.66 |
% |
GSK_PKIS: CDK3/cyclinE mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Cyclin-dependent kinase 4 |
Inhibition |
= |
-6.94 |
% |
GSK_PKIS: CDK4/cyclinD mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Cyclin-dependent kinase 5 |
Inhibition |
= |
-3.69 |
% |
GSK_PKIS: CDK5/p35 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Cyclin-dependent kinase 6 |
Inhibition |
= |
-0.76 |
% |
GSK_PKIS: CDK6/cyclinD3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Dual specificity protein kinase CLK2 |
Inhibition |
= |
3.04 |
% |
GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Dual specificity protein kinase CLK3 |
Inhibition |
= |
-3.93 |
% |
GSK_PKIS: CLK3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A |
Inhibition |
= |
-3.39 |
% |
GSK_PKIS: DYRK1A mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1B |
Inhibition |
= |
-3.26 |
% |
GSK_PKIS: DYRK1B mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 |
Inhibition |
= |
0.79 |
% |
GSK_PKIS: DYRK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Glycogen synthase kinase-3 alpha |
Inhibition |
= |
3.64 |
% |
GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Glycogen synthase kinase-3 beta |
Inhibition |
= |
3.02 |
% |
GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Homeodomain-interacting protein kinase 1 |
Inhibition |
= |
-2.33 |
% |
GSK_PKIS: HIPK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Homeodomain-interacting protein kinase 4 |
Inhibition |
= |
-0.66 |
% |
GSK_PKIS: HIPK4 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
c-Jun N-terminal kinase 2 |
Inhibition |
= |
-1.67 |
% |
GSK_PKIS: JNK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase ERK2 |
Inhibition |
= |
-1.43 |
% |
GSK_PKIS: MAPK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase ERK1 |
Inhibition |
= |
0.83 |
% |
GSK_PKIS: MAPK3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase SRPK3 |
Inhibition |
= |
-0.93 |
% |
GSK_PKIS: MSSK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase p38 alpha |
Inhibition |
= |
2.63 |
% |
GSK_PKIS: P38alpha mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase p38 beta |
Inhibition |
= |
1.35 |
% |
GSK_PKIS: P38beta mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase p38 delta |
Inhibition |
= |
-0.64 |
% |
GSK_PKIS: P38delta mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase p38 gamma |
Inhibition |
= |
-1.4 |
% |
GSK_PKIS: P38gamma mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase SRPK1 |
Inhibition |
= |
1.41 |
% |
GSK_PKIS: SRPK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
PI3-kinase p110-alpha subunit |
Inhibition |
= |
-0.19 |
% |
GSK_PKIS: PI3K-alpha mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
PI3-kinase p110-delta subunit |
Inhibition |
= |
-1.29 |
% |
GSK_PKIS: PI3K-delta mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
PI4-kinase beta subunit |
Inhibition |
= |
5.84 |
% |
GSK_PKIS: PI4K-beta mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Sphingosine kinase 1 |
Inhibition |
= |
-0.37 |
% |
GSK_PKIS: SPHK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Sphingosine kinase 2 |
Inhibition |
= |
0.58 |
% |
GSK_PKIS: SPHK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Casein kinase II alpha |
Inhibition |
= |
0.97 |
% |
GSK_PKIS: CK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Inhibitor of nuclear factor kappa B kinase alpha subunit |
Inhibition |
= |
0.84 |
% |
GSK_PKIS: IKKA mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Inhibitor of nuclear factor kappa B kinase beta subunit |
Inhibition |
= |
1.12 |
% |
GSK_PKIS: IKKB mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Inhibitor of nuclear factor kappa B kinase epsilon subunit |
Inhibition |
= |
3.81 |
% |
GSK_PKIS: IKKE mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Nek1 |
Inhibition |
= |
0.0 |
% |
GSK_PKIS: NEK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase NEK2 |
Inhibition |
= |
-1.74 |
% |
GSK_PKIS: NEK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase NEK6 |
Inhibition |
= |
2.37 |
% |
GSK_PKIS: NEK6 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase NEK7 |
Inhibition |
= |
-0.81 |
% |
GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase NEK9 |
Inhibition |
= |
0.98 |
% |
GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PLK1 |
Inhibition |
= |
-1.9 |
% |
GSK_PKIS: PLK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Dual specificity protein kinase TTK |
Inhibition |
= |
0.25 |
% |
GSK_PKIS: TTK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Aurora-A |
Inhibition |
= |
-0.8 |
% |
GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Aurora-B |
Inhibition |
= |
0.64 |
% |
GSK_PKIS: Aurora-B mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Aurora-C |
Inhibition |
= |
0.73 |
% |
GSK_PKIS: Aurora-C mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase 10 |
Inhibition |
= |
4.49 |
% |
GSK_PKIS: LOK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Mitogen-activated protein kinase kinase kinase kinase 2 |
Inhibition |
= |
1.19 |
% |
GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Mitogen-activated protein kinase kinase kinase kinase 4 |
Inhibition |
= |
1.22 |
% |
GSK_PKIS: MAP4K4 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Dual specificity mitogen-activated protein kinase kinase 1 |
Inhibition |
= |
-0.13 |
% |
GSK_PKIS: MEK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Misshapen-like kinase 1 |
Inhibition |
= |
2.27 |
% |
GSK_PKIS: MINK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase MST1 |
Inhibition |
= |
3.6 |
% |
GSK_PKIS: MST1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase MST2 |
Inhibition |
= |
4.46 |
% |
GSK_PKIS: MST2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase MST4 |
Inhibition |
= |
0.98 |
% |
GSK_PKIS: MST4 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PAK 1 |
Inhibition |
= |
2.37 |
% |
GSK_PKIS: PAK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PAK 2 |
Inhibition |
= |
-1.03 |
% |
GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PAK 3 |
Inhibition |
= |
-1.14 |
% |
GSK_PKIS: PAK3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PAK7 |
Inhibition |
= |
6.09 |
% |
GSK_PKIS: PAK5 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PAK6 |
Inhibition |
= |
5.99 |
% |
GSK_PKIS: PAK6 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL |
Inhibition |
= |
30.77 |
% |
GSK_PKIS: ABL1 (E255K mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL |
Inhibition |
= |
47.15 |
% |
GSK_PKIS: ABL1 (H396P mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL |
Inhibition |
= |
44.72 |
% |
GSK_PKIS: ABL1 (M351T mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL |
Inhibition |
= |
40.08 |
% |
GSK_PKIS: ABL1 (Q252H mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL |
Inhibition |
= |
1.94 |
% |
GSK_PKIS: ABL1 (T315I mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL |
Inhibition |
= |
44.65 |
% |
GSK_PKIS: ABL1 (Y253F mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL |
Inhibition |
= |
28.96 |
% |
GSK_PKIS: ABL1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
ALK tyrosine kinase receptor |
Inhibition |
= |
-1.9 |
% |
GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL2 |
Inhibition |
= |
12.69 |
% |
GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase receptor UFO |
Inhibition |
= |
3.99 |
% |
GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase BLK |
Inhibition |
= |
-0.3 |
% |
GSK_PKIS: BLK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase BMX |
Inhibition |
= |
-0.75 |
% |
GSK_PKIS: BMX mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase BRK |
Inhibition |
= |
0.43 |
% |
GSK_PKIS: BRK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase BTK |
Inhibition |
= |
-2.61 |
% |
GSK_PKIS: BTK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase CSK |
Inhibition |
= |
1.91 |
% |
GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Discoidin domain-containing receptor 2 |
Inhibition |
= |
-0.19 |
% |
GSK_PKIS: DDR2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Epidermal growth factor receptor erbB1 |
Inhibition |
= |
2.02 |
% |
GSK_PKIS: EGFR mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Epidermal growth factor receptor erbB1 |
Inhibition |
= |
5.72 |
% |
GSK_PKIS: EGFR (L858R mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Epidermal growth factor receptor erbB1 |
Inhibition |
= |
1.61 |
% |
GSK_PKIS: EGFR (L861Q mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Epidermal growth factor receptor erbB1 |
Inhibition |
= |
-0.92 |
% |
GSK_PKIS: EGFR (T790M mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Epidermal growth factor receptor erbB1 |
Inhibition |
= |
-1.35 |
% |
GSK_PKIS: EGFR (T790M-L858R mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Ephrin type-A receptor 2 |
Inhibition |
= |
-0.82 |
% |
GSK_PKIS: EPHA2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Ephrin type-A receptor 3 |
Inhibition |
= |
-3.39 |
% |
GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Ephrin type-A receptor 4 |
Inhibition |
= |
3.18 |
% |
GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Ephrin type-B receptor 2 |
Inhibition |
= |
2.42 |
% |
GSK_PKIS: EPHB2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Ephrin type-B receptor 3 |
Inhibition |
= |
-8.69 |
% |
GSK_PKIS: EPHB3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Ephrin type-B receptor 4 |
Inhibition |
= |
-2.1 |
% |
GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Receptor protein-tyrosine kinase erbB-2 |
Inhibition |
= |
0.94 |
% |
GSK_PKIS: ERBB2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Receptor protein-tyrosine kinase erbB-4 |
Inhibition |
= |
-3.73 |
% |
GSK_PKIS: ERBB4 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase FER |
Inhibition |
= |
4.18 |
% |
GSK_PKIS: FER mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase FES |
Inhibition |
= |
-0.04 |
% |
GSK_PKIS: FES mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Fibroblast growth factor receptor 1 |
Inhibition |
= |
-7.19 |
% |
GSK_PKIS: FGFR1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Fibroblast growth factor receptor 2 |
Inhibition |
= |
-3.25 |
% |
GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Fibroblast growth factor receptor 3 |
Inhibition |
= |
-3.58 |
% |
GSK_PKIS: FGFR3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Fibroblast growth factor receptor 4 |
Inhibition |
= |
-4.06 |
% |
GSK_PKIS: FGFR4 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase FGR |
Inhibition |
= |
6.79 |
% |
GSK_PKIS: FGR mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Vascular endothelial growth factor receptor 1 |
Inhibition |
= |
-1.12 |
% |
GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase receptor FLT3 |
Inhibition |
= |
0.88 |
% |
GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase receptor FLT3 |
Inhibition |
= |
7.7 |
% |
GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Vascular endothelial growth factor receptor 3 |
Inhibition |
= |
-13.03 |
% |
GSK_PKIS: FLT4 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Macrophage colony stimulating factor receptor |
Inhibition |
= |
4.43 |
% |
GSK_PKIS: FMS mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase FYN |
Inhibition |
= |
-0.06 |
% |
GSK_PKIS: FYN mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase HCK |
Inhibition |
= |
0.9 |
% |
GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Insulin-like growth factor I receptor |
Inhibition |
= |
-11.38 |
% |
GSK_PKIS: IGF1R mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Insulin receptor |
Inhibition |
= |
-2.78 |
% |
GSK_PKIS: INSR mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Insulin receptor-related protein |
Inhibition |
= |
1.0 |
% |
GSK_PKIS: IRR mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ITK/TSK |
Inhibition |
= |
-2.76 |
% |
GSK_PKIS: ITK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase JAK1 |
Inhibition |
= |
4.44 |
% |
GSK_PKIS: JAK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase JAK2 |
Inhibition |
= |
0.27 |
% |
GSK_PKIS: JAK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase JAK3 |
Inhibition |
= |
-2.48 |
% |
GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Vascular endothelial growth factor receptor 2 |
Inhibition |
= |
-0.11 |
% |
GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Stem cell growth factor receptor |
Inhibition |
= |
33.37 |
% |
GSK_PKIS: KIT mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Stem cell growth factor receptor |
Inhibition |
= |
0.1 |
% |
GSK_PKIS: KIT (D816V mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Stem cell growth factor receptor |
Inhibition |
= |
-2.23 |
% |
GSK_PKIS: KIT (T6701 mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Stem cell growth factor receptor |
Inhibition |
= |
3.15 |
% |
GSK_PKIS: KIT (V560G mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase LCK |
Inhibition |
= |
3.69 |
% |
GSK_PKIS: LCK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Leukocyte tyrosine kinase receptor |
Inhibition |
= |
-1.69 |
% |
GSK_PKIS: LTK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase Lyn |
Inhibition |
= |
7.17 |
% |
GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase Lyn |
Inhibition |
= |
6.07 |
% |
GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Proto-oncogene tyrosine-protein kinase MER |
Inhibition |
= |
0.12 |
% |
GSK_PKIS: MER mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Hepatocyte growth factor receptor |
Inhibition |
= |
0.87 |
% |
GSK_PKIS: MET mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Muscle, skeletal receptor tyrosine protein kinase |
Inhibition |
= |
2.4 |
% |
GSK_PKIS: MUSK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Platelet-derived growth factor receptor alpha |
Inhibition |
= |
17.93 |
% |
GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Platelet-derived growth factor receptor alpha |
Inhibition |
= |
4.61 |
% |
GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Platelet-derived growth factor receptor alpha |
Inhibition |
= |
2.14 |
% |
GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Platelet-derived growth factor receptor alpha |
Inhibition |
= |
10.33 |
% |
GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Platelet-derived growth factor receptor beta |
Inhibition |
= |
13.18 |
% |
GSK_PKIS: PDGFRB mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase FRK |
Inhibition |
= |
-0.1 |
% |
GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Protein tyrosine kinase 2 beta |
Inhibition |
= |
-4.12 |
% |
GSK_PKIS: PYK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase receptor RET |
Inhibition |
= |
3.89 |
% |
GSK_PKIS: RET mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase receptor RET |
Inhibition |
= |
-0.06 |
% |
GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase receptor RET |
Inhibition |
= |
2.51 |
% |
GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Macrophage-stimulating protein receptor |
Inhibition |
= |
0.89 |
% |
GSK_PKIS: RON mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Proto-oncogene tyrosine-protein kinase ROS |
Inhibition |
= |
-1.03 |
% |
GSK_PKIS: ROS mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase SRC |
Inhibition |
= |
12.48 |
% |
GSK_PKIS: SRC mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase Srms |
Inhibition |
= |
2.47 |
% |
GSK_PKIS: SRMS mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase SYK |
Inhibition |
= |
1.9 |
% |
GSK_PKIS: SYK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase TEC |
Inhibition |
= |
-2.49 |
% |
GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase TIE-2 |
Inhibition |
= |
-0.9 |
% |
GSK_PKIS: TIE2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Non-receptor tyrosine-protein kinase TNK1 |
Inhibition |
= |
1.98 |
% |
GSK_PKIS: TNK1 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine kinase non-receptor protein 2 |
Inhibition |
= |
0.06 |
% |
GSK_PKIS: TNK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Nerve growth factor receptor Trk-A |
Inhibition |
= |
-1.67 |
% |
GSK_PKIS: TRKA mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Neurotrophic tyrosine kinase receptor type 2 |
Inhibition |
= |
0.22 |
% |
GSK_PKIS: TRKB mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
NT-3 growth factor receptor |
Inhibition |
= |
0.58 |
% |
GSK_PKIS: TRKC mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase TXK |
Inhibition |
= |
-1.8 |
% |
GSK_PKIS: TXK mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase TYK2 |
Inhibition |
= |
3.07 |
% |
GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase receptor TYRO3 |
Inhibition |
= |
1.07 |
% |
GSK_PKIS: TYRO3 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase YES |
Inhibition |
= |
7.55 |
% |
GSK_PKIS: YES mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ZAP-70 |
Inhibition |
= |
-2.42 |
% |
GSK_PKIS: ZAP70 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase B-raf |
Inhibition |
= |
-0.31 |
% |
GSK_PKIS: BRAF mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase B-raf |
Inhibition |
= |
-0.89 |
% |
GSK_PKIS: BRAF (V599E mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase RAF |
Inhibition |
= |
-3.41 |
% |
GSK_PKIS: CRAF mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Interleukin-1 receptor-associated kinase 4 |
Inhibition |
= |
-2.35 |
% |
GSK_PKIS: IRAK4 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Leucine-rich repeat serine/threonine-protein kinase 2 |
Inhibition |
= |
-1.76 |
% |
GSK_PKIS: LRRK2 mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Leucine-rich repeat serine/threonine-protein kinase 2 |
Inhibition |
= |
0.11 |
% |
GSK_PKIS: LRRK2 (G2019S mutant) mean inhibition at 0.1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase AKT |
Inhibition |
= |
-3.41 |
% |
GSK_PKIS: AKT1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase AKT2 |
Inhibition |
= |
-4.73 |
% |
GSK_PKIS: AKT2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase AKT3 |
Inhibition |
= |
-3.32 |
% |
GSK_PKIS: AKT3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
G protein-coupled receptor kinase 6 |
Inhibition |
= |
8.28 |
% |
GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
G protein-coupled receptor kinase 7 |
Inhibition |
= |
5.64 |
% |
GSK_PKIS: GRK7 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase MRCK-A |
Inhibition |
= |
3.69 |
% |
GSK_PKIS: MRCKA mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase MRCK beta |
Inhibition |
= |
0.7 |
% |
GSK_PKIS: MRCKB mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Ribosomal protein S6 kinase alpha 5 |
Inhibition |
= |
1.02 |
% |
GSK_PKIS: MSK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Ribosomal protein S6 kinase alpha 4 |
Inhibition |
= |
3.95 |
% |
GSK_PKIS: MSK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Ribosomal protein S6 kinase 1 |
Inhibition |
= |
1.15 |
% |
GSK_PKIS: p70s6K1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Pyruvate dehydrogenase kinase isoform 1 |
Inhibition |
= |
1.39 |
% |
GSK_PKIS: PDK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
cAMP-dependent protein kinase alpha-catalytic subunit |
Inhibition |
= |
0.18 |
% |
GSK_PKIS: PKA mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C alpha |
Inhibition |
= |
-3.28 |
% |
GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C beta |
Inhibition |
= |
5.82 |
% |
GSK_PKIS: PKC-beta1 (splice variant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C eta |
Inhibition |
= |
0.69 |
% |
GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C gamma |
Inhibition |
= |
3.14 |
% |
GSK_PKIS: PKC-gamma mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C iota |
Inhibition |
= |
-0.97 |
% |
GSK_PKIS: PKC-iota mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C theta |
Inhibition |
= |
4.42 |
% |
GSK_PKIS: PKC-theta mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C beta |
Inhibition |
= |
2.1 |
% |
GSK_PKIS: PKC-beta2 (splice variant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C mu |
Inhibition |
= |
-5.45 |
% |
GSK_PKIS: PRKD1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase D2 |
Inhibition |
= |
-5.5 |
% |
GSK_PKIS: PRKD2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Protein kinase C nu |
Inhibition |
= |
-4.97 |
% |
GSK_PKIS: PRKD3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
cGMP-dependent protein kinase 1 beta |
Inhibition |
= |
3.77 |
% |
GSK_PKIS: PRKG1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
cGMP-dependent protein kinase 2 |
Inhibition |
= |
4.98 |
% |
GSK_PKIS: PRKG2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PRKX |
Inhibition |
= |
5.16 |
% |
GSK_PKIS: PRKX mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Rho-associated protein kinase 1 |
Inhibition |
= |
1.07 |
% |
GSK_PKIS: ROCK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Rho-associated protein kinase 2 |
Inhibition |
= |
6.91 |
% |
GSK_PKIS: ROCK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Ribosomal protein S6 kinase alpha 1 |
Inhibition |
= |
4.66 |
% |
GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Ribosomal protein S6 kinase alpha 3 |
Inhibition |
= |
4.76 |
% |
GSK_PKIS: RSK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Ribosomal protein S6 kinase alpha 2 |
Inhibition |
= |
0.82 |
% |
GSK_PKIS: RSK3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Ribosomal protein S6 kinase alpha 6 |
Inhibition |
= |
1.9 |
% |
GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Sgk1 |
Inhibition |
= |
4.05 |
% |
GSK_PKIS: SGK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Sgk2 |
Inhibition |
= |
2.41 |
% |
GSK_PKIS: SGK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Sgk3 |
Inhibition |
= |
3.83 |
% |
GSK_PKIS: SGK3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
AMP-activated protein kinase, alpha-1 subunit |
Inhibition |
= |
3.79 |
% |
GSK_PKIS: AMPKA1 (A1B1G1) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
AMP-activated protein kinase, alpha-2 subunit |
Inhibition |
= |
1.47 |
% |
GSK_PKIS: AMPKA2 (A2B1G1) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
NUAK family SNF1-like kinase 1 |
Inhibition |
= |
22.32 |
% |
GSK_PKIS: ARK5 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
BR serine/threonine-protein kinase 1 |
Inhibition |
= |
4.34 |
% |
GSK_PKIS: BRSK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
BR serine/threonine-protein kinase 2 |
Inhibition |
= |
6.3 |
% |
GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
CaM kinase I delta |
Inhibition |
= |
-0.39 |
% |
GSK_PKIS: CAMK1D mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
CaM kinase II alpha |
Inhibition |
= |
1.18 |
% |
GSK_PKIS: CAMK2A mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
CaM kinase II delta |
Inhibition |
= |
-1.61 |
% |
GSK_PKIS: CAMK2D mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
CaM kinase IV |
Inhibition |
= |
-5.3 |
% |
GSK_PKIS: CAMK4 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Chk1 |
Inhibition |
= |
0.31 |
% |
GSK_PKIS: CHEK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Chk2 |
Inhibition |
= |
-0.32 |
% |
GSK_PKIS: CHEK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Death-associated protein kinase 1 |
Inhibition |
= |
-2.81 |
% |
GSK_PKIS: DAPK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase DCLK2 |
Inhibition |
= |
-0.03 |
% |
GSK_PKIS: DCAMKL2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase-activated protein kinase 2 |
Inhibition |
= |
-0.48 |
% |
GSK_PKIS: MAPKAPK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase-activated protein kinase 3 |
Inhibition |
= |
-2.07 |
% |
GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase MARK1 |
Inhibition |
= |
6.09 |
% |
GSK_PKIS: MARK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase c-TAK1 |
Inhibition |
= |
3.88 |
% |
GSK_PKIS: MARK3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
MAP/microtubule affinity-regulating kinase 4 |
Inhibition |
= |
4.83 |
% |
GSK_PKIS: MARK4 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Maternal embryonic leucine zipper kinase |
Inhibition |
= |
-4.7 |
% |
GSK_PKIS: MELK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase-interacting serine/threonine-protein kinase MNK1 |
Inhibition |
= |
16.5 |
% |
GSK_PKIS: MKNK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase signal-integrating kinase 2 |
Inhibition |
= |
13.69 |
% |
GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
MAP/microtubule affinity-regulating kinase 2 |
Inhibition |
= |
4.05 |
% |
GSK_PKIS: PAR-1Balpha mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
PAS domain-containing serine/threonine-protein kinase |
Inhibition |
= |
4.15 |
% |
GSK_PKIS: PASK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Phosphorylase kinase gamma subunit 1 |
Inhibition |
= |
2.55 |
% |
GSK_PKIS: PHKG1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Phosphorylase kinase gamma subunit 2 |
Inhibition |
= |
6.48 |
% |
GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PIM1 |
Inhibition |
= |
-0.03 |
% |
GSK_PKIS: PIM1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PIM2 |
Inhibition |
= |
-3.43 |
% |
GSK_PKIS: PIM2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PIM3 |
Inhibition |
= |
6.5 |
% |
GSK_PKIS: PIM3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase-activated protein kinase 5 |
Inhibition |
= |
2.56 |
% |
GSK_PKIS: PRAK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase SIK1 |
Inhibition |
= |
12.03 |
% |
GSK_PKIS: SNF1LK (SIK) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase SIK2 |
Inhibition |
= |
34.08 |
% |
GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase TBK1 |
Inhibition |
= |
2.56 |
% |
GSK_PKIS: TBK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Testis-specific serine/threonine-protein kinase 1 |
Inhibition |
= |
5.32 |
% |
GSK_PKIS: TSSK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Testis-specific serine/threonine-protein kinase 2 |
Inhibition |
= |
4.98 |
% |
GSK_PKIS: TSSK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Casein kinase I alpha |
Inhibition |
= |
0.8 |
% |
GSK_PKIS: CK1a mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Casein kinase I gamma 1 |
Inhibition |
= |
-4.26 |
% |
GSK_PKIS: CK1-g1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Casein kinase I gamma 2 |
Inhibition |
= |
-5.36 |
% |
GSK_PKIS: CK1-g2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Casein kinase I isoform gamma-3 |
Inhibition |
= |
-3.3 |
% |
GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Cyclin-dependent kinase 1 |
Inhibition |
= |
0.55 |
% |
GSK_PKIS: CDK1/cyclinB mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Cyclin-dependent kinase 2 |
Inhibition |
= |
8.02 |
% |
GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Cyclin-dependent kinase 2 |
Inhibition |
= |
-2.32 |
% |
GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
CDK3/Cyclin E |
Inhibition |
= |
0.9 |
% |
GSK_PKIS: CDK3/cyclinE mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Cyclin-dependent kinase 4 |
Inhibition |
= |
-4.27 |
% |
GSK_PKIS: CDK4/cyclinD mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Cyclin-dependent kinase 5 |
Inhibition |
= |
-0.49 |
% |
GSK_PKIS: CDK5/p35 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Cyclin-dependent kinase 6 |
Inhibition |
= |
-8.82 |
% |
GSK_PKIS: CDK6/cyclinD3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Dual specificity protein kinase CLK2 |
Inhibition |
= |
5.72 |
% |
GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Dual specificity protein kinase CLK3 |
Inhibition |
= |
-2.92 |
% |
GSK_PKIS: CLK3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A |
Inhibition |
= |
2.17 |
% |
GSK_PKIS: DYRK1A mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1B |
Inhibition |
= |
-0.65 |
% |
GSK_PKIS: DYRK1B mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 |
Inhibition |
= |
2.96 |
% |
GSK_PKIS: DYRK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Glycogen synthase kinase-3 alpha |
Inhibition |
= |
34.68 |
% |
GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Glycogen synthase kinase-3 beta |
Inhibition |
= |
32.38 |
% |
GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Homeodomain-interacting protein kinase 1 |
Inhibition |
= |
-0.32 |
% |
GSK_PKIS: HIPK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Homeodomain-interacting protein kinase 4 |
Inhibition |
= |
3.74 |
% |
GSK_PKIS: HIPK4 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
c-Jun N-terminal kinase 2 |
Inhibition |
= |
-0.57 |
% |
GSK_PKIS: JNK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase ERK2 |
Inhibition |
= |
-0.07 |
% |
GSK_PKIS: MAPK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase ERK1 |
Inhibition |
= |
2.27 |
% |
GSK_PKIS: MAPK3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase SRPK3 |
Inhibition |
= |
0.28 |
% |
GSK_PKIS: MSSK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase p38 alpha |
Inhibition |
= |
-0.98 |
% |
GSK_PKIS: P38alpha mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase p38 beta |
Inhibition |
= |
0.89 |
% |
GSK_PKIS: P38beta mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase p38 delta |
Inhibition |
= |
-2.04 |
% |
GSK_PKIS: P38delta mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
MAP kinase p38 gamma |
Inhibition |
= |
-1.27 |
% |
GSK_PKIS: P38gamma mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase SRPK1 |
Inhibition |
= |
4.2 |
% |
GSK_PKIS: SRPK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
PI3-kinase p110-alpha subunit |
Inhibition |
= |
-3.79 |
% |
GSK_PKIS: PI3K-alpha mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
PI3-kinase p110-delta subunit |
Inhibition |
= |
-2.3 |
% |
GSK_PKIS: PI3K-delta mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
PI4-kinase beta subunit |
Inhibition |
= |
-1.85 |
% |
GSK_PKIS: PI4K-beta mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Sphingosine kinase 1 |
Inhibition |
= |
0.02 |
% |
GSK_PKIS: SPHK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Sphingosine kinase 2 |
Inhibition |
= |
-0.25 |
% |
GSK_PKIS: SPHK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Casein kinase II alpha |
Inhibition |
= |
10.75 |
% |
GSK_PKIS: CK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Inhibitor of nuclear factor kappa B kinase alpha subunit |
Inhibition |
= |
-1.74 |
% |
GSK_PKIS: IKKA mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Inhibitor of nuclear factor kappa B kinase beta subunit |
Inhibition |
= |
3.32 |
% |
GSK_PKIS: IKKB mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Inhibitor of nuclear factor kappa B kinase epsilon subunit |
Inhibition |
= |
4.51 |
% |
GSK_PKIS: IKKE mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Nek1 |
Inhibition |
= |
9.07 |
% |
GSK_PKIS: NEK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase NEK2 |
Inhibition |
= |
-1.3 |
% |
GSK_PKIS: NEK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase NEK6 |
Inhibition |
= |
2.69 |
% |
GSK_PKIS: NEK6 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase NEK7 |
Inhibition |
= |
-2.76 |
% |
GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase NEK9 |
Inhibition |
= |
5.21 |
% |
GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PLK1 |
Inhibition |
= |
-0.54 |
% |
GSK_PKIS: PLK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Dual specificity protein kinase TTK |
Inhibition |
= |
5.77 |
% |
GSK_PKIS: TTK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Aurora-A |
Inhibition |
= |
13.0 |
% |
GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Aurora-B |
Inhibition |
= |
7.54 |
% |
GSK_PKIS: Aurora-B mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase Aurora-C |
Inhibition |
= |
-1.49 |
% |
GSK_PKIS: Aurora-C mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase 10 |
Inhibition |
= |
16.32 |
% |
GSK_PKIS: LOK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Mitogen-activated protein kinase kinase kinase kinase 2 |
Inhibition |
= |
1.25 |
% |
GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Mitogen-activated protein kinase kinase kinase kinase 4 |
Inhibition |
= |
16.89 |
% |
GSK_PKIS: MAP4K4 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Dual specificity mitogen-activated protein kinase kinase 1 |
Inhibition |
= |
-0.71 |
% |
GSK_PKIS: MEK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Misshapen-like kinase 1 |
Inhibition |
= |
16.85 |
% |
GSK_PKIS: MINK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase MST1 |
Inhibition |
= |
7.14 |
% |
GSK_PKIS: MST1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase MST2 |
Inhibition |
= |
7.42 |
% |
GSK_PKIS: MST2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase MST4 |
Inhibition |
= |
-2.88 |
% |
GSK_PKIS: MST4 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PAK 1 |
Inhibition |
= |
1.58 |
% |
GSK_PKIS: PAK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PAK 2 |
Inhibition |
= |
-0.99 |
% |
GSK_PKIS: PAK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PAK 3 |
Inhibition |
= |
0.31 |
% |
GSK_PKIS: PAK3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PAK7 |
Inhibition |
= |
10.85 |
% |
GSK_PKIS: PAK5 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase PAK6 |
Inhibition |
= |
3.44 |
% |
GSK_PKIS: PAK6 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL |
Inhibition |
= |
80.15 |
% |
GSK_PKIS: ABL1 (E255K mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL |
Inhibition |
= |
87.14 |
% |
GSK_PKIS: ABL1 (H396P mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL |
Inhibition |
= |
88.06 |
% |
GSK_PKIS: ABL1 (M351T mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL |
Inhibition |
= |
84.24 |
% |
GSK_PKIS: ABL1 (Q252H mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL |
Inhibition |
= |
28.49 |
% |
GSK_PKIS: ABL1 (T315I mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL |
Inhibition |
= |
85.3 |
% |
GSK_PKIS: ABL1 (Y253F mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL |
Inhibition |
= |
72.16 |
% |
GSK_PKIS: ABL1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
ALK tyrosine kinase receptor |
Inhibition |
= |
-4.64 |
% |
GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ABL2 |
Inhibition |
= |
59.45 |
% |
GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase receptor UFO |
Inhibition |
= |
-2.08 |
% |
GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase BLK |
Inhibition |
= |
15.75 |
% |
GSK_PKIS: BLK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase BMX |
Inhibition |
= |
16.12 |
% |
GSK_PKIS: BMX mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase BRK |
Inhibition |
= |
15.2 |
% |
GSK_PKIS: BRK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase BTK |
Inhibition |
= |
-2.79 |
% |
GSK_PKIS: BTK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase CSK |
Inhibition |
= |
7.17 |
% |
GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Discoidin domain-containing receptor 2 |
Inhibition |
= |
1.99 |
% |
GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Epidermal growth factor receptor erbB1 |
Inhibition |
= |
8.31 |
% |
GSK_PKIS: EGFR mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Epidermal growth factor receptor erbB1 |
Inhibition |
= |
30.83 |
% |
GSK_PKIS: EGFR (L858R mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Epidermal growth factor receptor erbB1 |
Inhibition |
= |
10.62 |
% |
GSK_PKIS: EGFR (L861Q mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Epidermal growth factor receptor erbB1 |
Inhibition |
= |
5.78 |
% |
GSK_PKIS: EGFR (T790M mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Epidermal growth factor receptor erbB1 |
Inhibition |
= |
6.65 |
% |
GSK_PKIS: EGFR (T790M-L858R mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Ephrin type-A receptor 2 |
Inhibition |
= |
0.55 |
% |
GSK_PKIS: EPHA2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Ephrin type-A receptor 3 |
Inhibition |
= |
-0.79 |
% |
GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Ephrin type-A receptor 4 |
Inhibition |
= |
25.6 |
% |
GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Ephrin type-B receptor 2 |
Inhibition |
= |
16.21 |
% |
GSK_PKIS: EPHB2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Ephrin type-B receptor 3 |
Inhibition |
= |
-4.51 |
% |
GSK_PKIS: EPHB3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Ephrin type-B receptor 4 |
Inhibition |
= |
0.65 |
% |
GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Receptor protein-tyrosine kinase erbB-2 |
Inhibition |
= |
7.49 |
% |
GSK_PKIS: ERBB2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Receptor protein-tyrosine kinase erbB-4 |
Inhibition |
= |
2.45 |
% |
GSK_PKIS: ERBB4 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase FER |
Inhibition |
= |
4.82 |
% |
GSK_PKIS: FER mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase FES |
Inhibition |
= |
-1.27 |
% |
GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Fibroblast growth factor receptor 1 |
Inhibition |
= |
-2.61 |
% |
GSK_PKIS: FGFR1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Fibroblast growth factor receptor 2 |
Inhibition |
= |
10.7 |
% |
GSK_PKIS: FGFR2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Fibroblast growth factor receptor 3 |
Inhibition |
= |
3.63 |
% |
GSK_PKIS: FGFR3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Fibroblast growth factor receptor 4 |
Inhibition |
= |
-3.96 |
% |
GSK_PKIS: FGFR4 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase FGR |
Inhibition |
= |
18.99 |
% |
GSK_PKIS: FGR mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Vascular endothelial growth factor receptor 1 |
Inhibition |
= |
1.4 |
% |
GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase receptor FLT3 |
Inhibition |
= |
6.95 |
% |
GSK_PKIS: FLT3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase receptor FLT3 |
Inhibition |
= |
9.6 |
% |
GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Vascular endothelial growth factor receptor 3 |
Inhibition |
= |
-4.88 |
% |
GSK_PKIS: FLT4 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Macrophage colony stimulating factor receptor |
Inhibition |
= |
24.9 |
% |
GSK_PKIS: FMS mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase FYN |
Inhibition |
= |
25.58 |
% |
GSK_PKIS: FYN mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase HCK |
Inhibition |
= |
16.31 |
% |
GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Insulin-like growth factor I receptor |
Inhibition |
= |
-8.19 |
% |
GSK_PKIS: IGF1R mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Insulin receptor |
Inhibition |
= |
-4.12 |
% |
GSK_PKIS: INSR mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Insulin receptor-related protein |
Inhibition |
= |
0.57 |
% |
GSK_PKIS: IRR mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ITK/TSK |
Inhibition |
= |
-1.27 |
% |
GSK_PKIS: ITK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase JAK1 |
Inhibition |
= |
16.28 |
% |
GSK_PKIS: JAK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase JAK2 |
Inhibition |
= |
0.37 |
% |
GSK_PKIS: JAK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase JAK3 |
Inhibition |
= |
-2.19 |
% |
GSK_PKIS: JAK3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Vascular endothelial growth factor receptor 2 |
Inhibition |
= |
11.2 |
% |
GSK_PKIS: KDR mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Stem cell growth factor receptor |
Inhibition |
= |
83.36 |
% |
GSK_PKIS: KIT mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Stem cell growth factor receptor |
Inhibition |
= |
3.79 |
% |
GSK_PKIS: KIT (D816V mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Stem cell growth factor receptor |
Inhibition |
= |
6.36 |
% |
GSK_PKIS: KIT (T6701 mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Stem cell growth factor receptor |
Inhibition |
= |
18.75 |
% |
GSK_PKIS: KIT (V560G mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase LCK |
Inhibition |
= |
29.31 |
% |
GSK_PKIS: LCK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Leukocyte tyrosine kinase receptor |
Inhibition |
= |
0.9 |
% |
GSK_PKIS: LTK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase Lyn |
Inhibition |
= |
47.25 |
% |
GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase Lyn |
Inhibition |
= |
41.63 |
% |
GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Proto-oncogene tyrosine-protein kinase MER |
Inhibition |
= |
4.47 |
% |
GSK_PKIS: MER mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Hepatocyte growth factor receptor |
Inhibition |
= |
6.87 |
% |
GSK_PKIS: MET mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Muscle, skeletal receptor tyrosine protein kinase |
Inhibition |
= |
17.06 |
% |
GSK_PKIS: MUSK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Platelet-derived growth factor receptor alpha |
Inhibition |
= |
53.62 |
% |
GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Platelet-derived growth factor receptor alpha |
Inhibition |
= |
45.61 |
% |
GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Platelet-derived growth factor receptor alpha |
Inhibition |
= |
18.33 |
% |
GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Platelet-derived growth factor receptor alpha |
Inhibition |
= |
50.95 |
% |
GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Platelet-derived growth factor receptor beta |
Inhibition |
= |
49.91 |
% |
GSK_PKIS: PDGFRB mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase FRK |
Inhibition |
= |
0.9 |
% |
GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Protein tyrosine kinase 2 beta |
Inhibition |
= |
10.54 |
% |
GSK_PKIS: PYK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase receptor RET |
Inhibition |
= |
13.94 |
% |
GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase receptor RET |
Inhibition |
= |
12.54 |
% |
GSK_PKIS: RET (V804L mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase receptor RET |
Inhibition |
= |
32.84 |
% |
GSK_PKIS: RET (Y791F mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Macrophage-stimulating protein receptor |
Inhibition |
= |
0.14 |
% |
GSK_PKIS: RON mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Proto-oncogene tyrosine-protein kinase ROS |
Inhibition |
= |
4.38 |
% |
GSK_PKIS: ROS mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase SRC |
Inhibition |
= |
50.4 |
% |
GSK_PKIS: SRC mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase Srms |
Inhibition |
= |
6.19 |
% |
GSK_PKIS: SRMS mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase SYK |
Inhibition |
= |
-1.09 |
% |
GSK_PKIS: SYK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase TEC |
Inhibition |
= |
5.03 |
% |
GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase TIE-2 |
Inhibition |
= |
9.67 |
% |
GSK_PKIS: TIE2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Non-receptor tyrosine-protein kinase TNK1 |
Inhibition |
= |
19.33 |
% |
GSK_PKIS: TNK1 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine kinase non-receptor protein 2 |
Inhibition |
= |
3.07 |
% |
GSK_PKIS: TNK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Nerve growth factor receptor Trk-A |
Inhibition |
= |
7.04 |
% |
GSK_PKIS: TRKA mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Neurotrophic tyrosine kinase receptor type 2 |
Inhibition |
= |
6.69 |
% |
GSK_PKIS: TRKB mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
NT-3 growth factor receptor |
Inhibition |
= |
9.77 |
% |
GSK_PKIS: TRKC mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase TXK |
Inhibition |
= |
4.69 |
% |
GSK_PKIS: TXK mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase TYK2 |
Inhibition |
= |
3.46 |
% |
GSK_PKIS: TYK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase receptor TYRO3 |
Inhibition |
= |
4.59 |
% |
GSK_PKIS: TYRO3 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase YES |
Inhibition |
= |
36.37 |
% |
GSK_PKIS: YES mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Tyrosine-protein kinase ZAP-70 |
Inhibition |
= |
-3.33 |
% |
GSK_PKIS: ZAP70 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase B-raf |
Inhibition |
= |
-1.09 |
% |
GSK_PKIS: BRAF mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase B-raf |
Inhibition |
= |
-0.68 |
% |
GSK_PKIS: BRAF (V599E mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Serine/threonine-protein kinase RAF |
Inhibition |
= |
-4.3 |
% |
GSK_PKIS: CRAF mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Interleukin-1 receptor-associated kinase 4 |
Inhibition |
= |
0.01 |
% |
GSK_PKIS: IRAK4 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Leucine-rich repeat serine/threonine-protein kinase 2 |
Inhibition |
= |
7.17 |
% |
GSK_PKIS: LRRK2 mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Leucine-rich repeat serine/threonine-protein kinase 2 |
Inhibition |
= |
18.11 |
% |
GSK_PKIS: LRRK2 (G2019S mutant) mean inhibition at 1 uM [Nanosyn] |
CHEMBL1961873 |
Inhibitor of nuclear factor kappa B kinase alpha subunit |
Inhibition |
= |
2.0 |
% |
GSK_PKIS: IKK-alpha % inhibition at 1 uM [UNC Frye lab] |
CHEMBL2007661 |
Inhibitor of nuclear factor kappa B kinase alpha subunit |
Inhibition |
= |
-3.0 |
% |
GSK_PKIS: IKK-alpha % inhibition at 1 uM [UNC Frye lab] |
CHEMBL2007661 |
Inhibitor of nuclear factor kappa B kinase beta subunit |
Inhibition |
= |
-3.0 |
% |
GSK_PKIS: IKK-beta % inhibition at 1 uM [UNC Frye lab] |
CHEMBL2007661 |
Inhibitor of nuclear factor kappa B kinase beta subunit |
Inhibition |
= |
4.0 |
% |
GSK_PKIS: IKK-beta % inhibition at 1 uM [UNC Frye lab] |
CHEMBL2007661 |
Inhibitor of nuclear factor kappa B kinase epsilon subunit |
Inhibition |
= |
1.0 |
% |
GSK_PKIS: IKK-epsilon % inhibition at 1 uM [UNC Frye lab] |
CHEMBL2007661 |
Inhibitor of nuclear factor kappa B kinase epsilon subunit |
Inhibition |
= |
0.0 |
% |
GSK_PKIS: IKK-epsilon % inhibition at 1 uM [UNC Frye lab] |
CHEMBL2007661 |
Proto-oncogene tyrosine-protein kinase MER |
Inhibition |
= |
-4.0 |
% |
GSK_PKIS: Mer Kinase % inhibition at 10 uM [UNC Frye lab] |
CHEMBL2007661 |
Unchecked |
Inhibition |
= |
10.0 |
% |
GSK_PKIS: PIP5K1 (Caliper assay) % inhibition at 5 uM [UNC Frye lab] |
CHEMBL2007661 |
Serine/threonine-protein kinase TBK1 |
Inhibition |
= |
4.0 |
% |
GSK_PKIS: TBK1 % inhibition at 1 uM [UNC Frye lab] |
CHEMBL2007661 |
Serine/threonine-protein kinase TBK1 |
Inhibition |
= |
-1.0 |
% |
GSK_PKIS: TBK1 % inhibition at 1 uM [UNC Frye lab] |
CHEMBL2007661 |
Renilla-luciferin 2-monooxygenase |
AC50 |
= |
|
nM |
GSK_PKIS: Inhibition of Sea Pansy Luciferase (Data from PubChem: AID 652015) [NIH NCATS] |
CHEMBL2303647 |
Luciferin 4-monooxygenase |
AC50 |
= |
16343.2 |
nM |
GSK_PKIS: Inhibition of Firefly Luciferase (Data from PubChem: AID 652016) [NIH NCATS] |
CHEMBL2303647 |